Treatment for Trichomoniasis
Metronidazole 500 mg orally twice daily for 7 days is the first-line treatment for trichomoniasis, as recommended by the CDC. 1
First-Line Treatment Options
Metronidazole regimen: 500 mg orally twice daily for 7 days 1, 2
- This is the preferred treatment regimen due to higher efficacy compared to single-dose therapy
- FDA-approved for both symptomatic and asymptomatic trichomoniasis 2
Alternative regimen: Tinidazole 2 g orally in a single dose 1, 3
- Recommended for patients with metronidazole allergy
- FDA-approved specifically for trichomoniasis caused by Trichomonas vaginalis 3
Evidence Supporting 7-Day Treatment
Recent evidence strongly favors the 7-day metronidazole regimen over single-dose therapy. A randomized controlled trial found that patients treated with the 7-day regimen were significantly less likely to test positive for T. vaginalis at follow-up compared to those receiving single-dose treatment (11% vs 19%, p<0.0001) 4.
Diagnostic Considerations
Before initiating treatment, diagnosis should be confirmed through one of these methods:
- Nucleic acid amplification tests (NAATs) - preferred method due to high sensitivity 1
- Culture - most sensitive commercially available method 1
- Wet mount microscopy - limited sensitivity (60-70%) 1
Partner Treatment
- All recent sexual partners (within 60 days) should be evaluated, tested, and treated 1
- Sexual partners should be treated simultaneously to prevent reinfection 3, 2
- Patients should abstain from sexual intercourse until both they and their partners have completed treatment 1
Important Precautions
- Alcohol interaction: Patients should avoid alcohol during treatment and for 24-48 hours afterward to prevent disulfiram-like reactions 1
- Monitoring: Improvement in symptoms should be seen within 72 hours of starting treatment 1
- Follow-up: Consider retesting 3 months after treatment due to high rates of reinfection 1
- Neurotoxicity risk: Avoid prolonged courses of metronidazole to prevent cumulative and potentially irreversible neurotoxicity 1
Special Populations
- Pregnancy: Metronidazole is contraindicated in the first trimester but may be used after the first trimester in a 2 g single dose 1
- HIV patients: Should receive the same treatment regimen as patients without HIV 1
Treatment Failures
If no improvement is observed within 72 hours:
- Reassess the diagnosis
- Consider alternative regimen
- Rule out reinfection from untreated partner
Common Pitfalls to Avoid
- Single-dose therapy: While historically used and still sometimes practiced, the 7-day regimen has demonstrated superior efficacy 4
- Inadequate partner treatment: Failure to treat partners simultaneously is a major cause of recurrent infection 1, 3, 2
- Alcohol consumption: Not warning patients about alcohol interaction can lead to severe adverse reactions
- Incomplete treatment course: Poor adherence to the 7-day regimen can result in treatment failure